Charles Schwab Investment Management Inc. lowered its position in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 14.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 179,022 shares of the company's stock after selling 29,910 shares during the period. Charles Schwab Investment Management Inc. owned 0.94% of USANA Health Sciences worth $6,789,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of USNA. Exchange Traded Concepts LLC increased its holdings in shares of USANA Health Sciences by 4.4% in the third quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company's stock valued at $292,000 after purchasing an additional 322 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of USANA Health Sciences by 9.2% in the first quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company's stock valued at $284,000 after purchasing an additional 494 shares in the last quarter. KBC Group NV increased its holdings in shares of USANA Health Sciences by 96.6% in the third quarter. KBC Group NV now owns 1,056 shares of the company's stock valued at $40,000 after purchasing an additional 519 shares in the last quarter. Public Sector Pension Investment Board increased its holdings in shares of USANA Health Sciences by 5.4% in the second quarter. Public Sector Pension Investment Board now owns 24,270 shares of the company's stock valued at $1,098,000 after purchasing an additional 1,242 shares in the last quarter. Finally, TD Asset Management Inc increased its holdings in shares of USANA Health Sciences by 26.4% in the second quarter. TD Asset Management Inc now owns 11,500 shares of the company's stock valued at $520,000 after purchasing an additional 2,400 shares in the last quarter. Institutional investors own 54.25% of the company's stock.
Analysts Set New Price Targets
Separately, DA Davidson lowered their price target on shares of USANA Health Sciences from $38.00 to $35.00 and set a "neutral" rating for the company in a report on Wednesday, October 23rd.
Read Our Latest Stock Report on USANA Health Sciences
Insider Activity
In related news, Director Gilbert A. Fuller sold 675 shares of the business's stock in a transaction on Monday, November 4th. The shares were sold at an average price of $37.71, for a total value of $25,454.25. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.33% of the stock is owned by company insiders.
USANA Health Sciences Stock Performance
USNA traded up $0.18 during trading on Thursday, reaching $37.92. 38,740 shares of the company's stock were exchanged, compared to its average volume of 80,799. The company's fifty day moving average price is $37.91 and its 200-day moving average price is $40.88. USANA Health Sciences, Inc. has a fifty-two week low of $34.15 and a fifty-two week high of $54.81. The firm has a market capitalization of $722.76 million, a PE ratio of 13.32, a P/E/G ratio of 1.27 and a beta of 0.89.
USANA Health Sciences (NYSE:USNA - Get Free Report) last announced its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.07. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The company had revenue of $200.22 million during the quarter, compared to analyst estimates of $208.45 million. During the same quarter in the previous year, the business earned $0.59 EPS. Research analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.
USANA Health Sciences Profile
(
Free Report)
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Further Reading
Before you consider USANA Health Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and USANA Health Sciences wasn't on the list.
While USANA Health Sciences currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
